Anthrax
Anthrax: a continuing concern in the era of bioterrorism.
Riedel S.
roc (Bayl Univ Med Cent). 2005 Jul; 18(3): 234-243.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1200731
A silent bomb: The risk of anthrax as a weapon of mass destruction.
Webb GF.
Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8): 4355-4356. published online before print April 7, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=153555
Novel Sample Preparation Method for Safe and Rapid Detection of Bacillus anthracis Spores in Environmental Powders and Nasal Swabs.
Luna VA, King D, Davis C, Rycerz T, Ewert M, Cannons A, Amuso P, Cattani J. J Clin Microbiol. 2003 Mar; 41(3): 1252-1255.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=150283
Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.
Brookmeyer R, Johnson E, Bollinger R.
Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17): 10129-10132. published online before print July 30, 2003 PMCID: 187789
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=187789
Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin.
Wang JY, Roehrl MH.
Med Immunol. 2005; 4: 4. published online before print March 24, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1079933
Is In Vitro Antibiotic Combination More Effective than Single-Drug Therapy against Anthrax?
Athamna A, Athamna M, Nura A, Shlyakov E, Bast DJ, Farrell D, Rubinstein E.
Antimicrob Agents Chemother. 2005 Apr; 49(4): 1323-1325.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1068588
Emergency response to an anthrax attack.
Wein LM, Craft DL, Kaplan EH.
Proc Natl Acad Sci U S A. 2003 Apr 1; 100(7): 4346-4351. published online before print March 21, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=153095
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid;=153095#supplementary-material-sec
In Vivo–produced Anthrax Toxin.
Fish DC, Lincoln RE.
J Bacteriol. 1968 Mar; 95(3): 919-924.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=252110
The host response to anthrax lethal toxin: unexpected observations.
Prince AS.
J Clin Invest. 2003 Sep 1; 112(5): 656-658.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=182215
Initiating informatics and GIS support for a field investigation of Bioterrorism: The New Jersey anthrax experience.
Zubieta JC, Skinner R, Dean AG.
Int J Health Geogr. 2003; 2: 8. published online before print November 16, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=293473
PATHOGENESIS OF INHALATION ANTHRAX.
Albrink WS. Bacteriol Rev. 1961 Sep; 25(3): 268-273.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=441103
USEFUL CRITERIA FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS AND RELATED SPECIES.
Burdon KL.
J Bacteriol. 1956 Jan; 71(1): 25-42.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=357732
Industrial inhalation Anthrax.
Brachman PS, Kaufman AF, Dalldorf FG.
Bacteriol Rev. 1966 Sep; 30(3): 646-659.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=378258
Back to Top
Bioterrorism/Biological Warfare
Bioterrorism: Implications for the Clinical Microbiologist.
Klietmann WF, Ruoff KL.
Clin Microbiol Rev. 2001 Apr; 14(2): 364-381.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=88979
Biocrimes, Microbial Forensics, and the Physician.
Schutzer SE, Budowle B, Atlas RM.
PLoS Med. 2005 Dec; 2(12): e337. published online before print September 27, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1236212
Role of the Hospital-Based Microbiology Laboratory in Preparation for and Response to a
Bioterrorism Event.
Snyder JW.
J Clin Microbiol. 2003 Jan; 41(1): 1-4.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=149646
Surge Capacity for Response to Bioterrorism in Hospital Clinical Microbiology Laboratories.
Shapiro DS.
J Clin Microbiol. 2003 Dec; 41(12): 5372-5376.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=308964
Learning about bioterrorism and chemical warfare: Medical students explore key threats.
[No authors listed]
West J Med. 2002 Jan; 176(1): 58-59.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1071656
Why global health matters to US primary care physicians.
Peabody JW, Feachem RG.
West J Med. 2001 Sep; 175(3): 153-154.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1071523
Near patient microbiological tests.
Borriello SP.
BMJ. 1999 Jul 31; 319(7205): 298-301.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1126935
Biological warfare and bioterrorism: a historical review.
Riedel S.
Proc (Bayl Univ Med Cent). 2004 Oct; 17(4): 400-406.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1200679
The problem of biological weapons.
Cole LA.
J Clin Invest. 2005 May 2; 115(5): 1110.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1087188
Bacterial toxins: a table of lethal amounts.
Gill DM.
Microbiol Rev. 1982 Mar; 46(1): 86-94.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=373212
The significance of chemical and biological warfare for the people.
Bennett IL Jr.
Proc Natl Acad Sci U S A. 1970 Jan; 65(1): 271-279.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=286221
Preparing for bioterrorism.
OReilly M.
CMAJ. 2002 May 28; 166(11): 1455.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid;=111239
The Informatics Response in Disaster, Terrorism, and War.
Teich JM, Wagner MM, Mackenzie CF, Schafer BG.
J Am Med Inform Assoc. 2002; 9(2): 97-104.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=344563
Biohazard.
Charatan F.
BMJ. 1999 Oct 16; 319(7216): 1077.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1116867
Deadly Alliances: Death, Disease, and the Global Politics of Public Health.
Gandy M.
PLoS Med. 2005 Jan; 2(1): e4. published online before print January 25, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=545197
Bioterrorism: Guidelines for Medical and Public Health Management.
Reacher M.
BMJ. 2003 Mar 22; 326(7390): 665.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid;=1125568
AMIA Recommendations for National Health Threat Surveillance and Response.
Brennan PF.
J Am Med Inform Assoc. 2002; 9(2): 204-206.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=344578
The World Trade Center Attack: Is critical care prepared for terrorism?
Kvetan V.
Crit Care. 2001; 5(6): 321-322. published online before print November 6, 2001
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=137380
Biological warfare and bioterrorism.
Beeching NJ, Dance DA, Miller AR, Spencer RC.
BMJ. 2002 Feb 9; 324(7333): 336-339.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1122269
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid;=1122269#supplementary-material-sec
Weapons of mass destruction—threats and responses.
Gosden C, Gardener D.
BMJ. 2005 Aug 13; 331(7513): 397-400.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid;=1184257
Biological warfare.
Suchard J.
West J Med. 1999 Apr; 170(4): 243.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1305563
Appropriate responses to bioterrorist threats : The health services will play a vital role in protection against covert releases.
Lightfoot N, Wale M, Spencer R, Nicoll A.
BMJ. 2001 Oct 20; 323(7318): 877-878.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1121424
Safe Food: Bacteria, biotechnology, and bioterrorism.
O’Doherty Jensen K.
J Clin Invest. 2004 Mar 15; 113(6): 787.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=362128
The problem of biological weapons.
Cole LA.
J Clin Invest. 2005 May 2; 115(5): 1110.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1087188
Response to bioterrorism : Terror weapons are regarded as weapons of mass destruction.
Lim MK.
BMJ. 2002 Feb 9; 324(7333): 362.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1122283
Chlorine Inactivation of Bacterial Bioterrorism Agents.
Rose LJ, Rice EW, Jensen B, Murga R, Peterson A, Donlan RM, Arduino MJ.
Appl Environ Microbiol. 2005 Jan; 71(1): 566-568.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=544226
Biodefense cost and consequence.
Goodman L.
J Clin Invest. 2004 Jul 1; 114(1): 2-3.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=437981
Harnessing new science is vital for biodefense and global health.
Alberts B, Fineberg HV.
Proc Natl Acad Sci U S A. 2004 Aug 3; 101(31): 11177. published online before print July 12, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=509179
The growing pains of biodefense.
Birmingham K.
J Clin Invest. 2003 Oct 1; 112(7): 970-971.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=198537
Provider and health care system response to a bioterrorist attack.
Malone JD.
Proc (Bayl Univ Med Cent). 2001 Jul; 14(3): 224-230.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1305821
Laboratory Safety Practices Associated with Potential Agents of Biocrime or Bioterrorism.
Sewell DL.
J Clin Microbiol. 2003 Jul; 41(7): 2801-2809.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=165388
Back to Top
Chemical Weapons/Warfare
Psychological implications of chemical and biological weapons : Long term social and psychological effects may be worse than acute ones.
Wessely S, Hyams KC, Bartholomew R. <
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1121425
Gas and germ warfare: international legal history and present status.
Bunn G.
Proc Natl Acad Sci U S A. 1970 Jan; 65(1): 253-260.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=286219
Chemical warfare from an ecological perspective.
Lenski RE, Riley MA.
Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2): 556-558.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=117343
Chemical warfare agents: toxicology and treatment.
Watson KD.
Med Hist. 1997 Apr; 41(2): 258.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1043932
Chemical weapons.
Evison D, Hinsley D, Rice P.
BMJ. 2002 Feb 9; 324(7333): 332-335.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1122267
The problem of secondary contamination following chemical agent release.
Baker D.
Crit Care. 2005; 9(4): 323-324. published online before print March 22, 2005
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid;=1269430
Chemical Mixtures: Considering the Evolution of Toxicology and Chemical Assessment.
Monosson E.
Environ Health Perspect. 2005 Apr; 113(4): 383-390. published online before print October 21, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=1278475
Back to Top
Dengue Fever
A model of dengue fever.
Derouich M, Boutayeb A, Twizell E.
Biomed Eng Online. 2003; 2: 4. published online before print February 19, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=153427
Dengue and Dengue Hemorrhagic Fever.
Gubler DJ.
Clin Microbiol Rev. 1998 Jul; 11(3): 480-496.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=88892
The dengue viruses.
Henchal EA, Putnak JR.
Clin Microbiol Rev. 1990 Oct; 3(4): 376-396.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=358169
Current Advances in Dengue Diagnosis.
Shu PY, Huang JH.
Clin Diagn Lab Immunol. 2004 Jul; 11(4): 642-650.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=440621
Dengue: defining protective versus pathologic immunity.
Rothman AL.
J Clin Invest. 2004 Apr 1; 113(7): 946-951.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=379334
Dengue fever: new paradigms for a changing epidemiology.
Guha-Sapir D, Schimmer B.
Emerg Themes Epidemiol. 2005; 2: 1. published online before print March 2, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=555563
Back to Top
Food Safety
The Role of internists during epidemics, outbreaks, and bioterrorist attacks.
Lee BY. J Gen Intern Med. 2007 January; 22(1): 131–136. Published online 2007 January 13.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1824729&blobtype=pdf
The color of hamburger: slow steps toward the development of a science-based food safety system in the United States.
Morris JG, Jr.
Trans Am Clin Climatol Assoc. 2003; 114: 191–202.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2194493&blobtype=pdf
Laboratory safety practices associated with potential agents of biocrime or bioterrorism.
Sewell DL.
J Clin Microbiol. 2003 July; 41(7): 2801–2809. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=165388&blobtype=pdf
Benefits of linking public health, animal health, and food safety surveillance.
Mann E.
Can Vet J. 2002 October; 43(10): 796–797. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=339620&blobtype=pdf
Mycotoxins.
Bennett JW, Klich M.
Clin Microbiol Rev. 2003 July; 16(3): 497–516. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=164220&blobtype=pdf
Implications of the World Trade Center attack for the public health and health care infrastructures.
Klitzman S, Freudenberg N.
Am J Public Health. 2003 March; 93(3): 400–406.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1447752&blobtype=pdf
Availability and perceived effectiveness of public health activities in the nation’s most populous communities.
Mays GP, Halverson PK, Baker EL, Stevens R, Vann JJ.
Am J Public Health. 2004 June; 94(6): 1019–1026.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1448383&blobtype=pdf
The threat of things biological.
VanderMeer DC.
Environ Health Perspect. 1998 June; 106(6): A280–A282.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1533003&blobtype=pdf
Food safety and foodborne disease in 21st century homes.
Scott E.
Can J Infect Dis. 2003 Sep–Oct; 14(5): 277–280.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2094945&blobtype=pdf
Making food safety an issue: internationalized food politics and French public health from the 1870s to the present.
Zylberman P.
Med Hist. 2004 January 1; 48(1): 1–28.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=546293&blobtype=pdf
Investigation of multistate foodborne disease outbreaks.
Sobel J, Griffin PM, Slutsker L, Swerdlow DL, Tauxe RV.
Public Health Rep. 2002 Jan–Feb; 117(1): 8–19.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1497402&blobtype=pdf
Back to Top
Francisella Tularensis (Tularemia)
STUDIES ON TULAREMIA: II. The Antigenic Properties of Variants of Pasteurella tularensis in Various Hosts.
Downs CM, Moody MD.
J Bacteriol. 1955 Sep; 70(3): 305-313.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=357686
STUDIES ON TULAREMIA: I. The Relation Between Certain Pathogenic and Immunogenic Properties of Variants of Pasteurella tularensis.
Moody MD, Downs CM.
J Bacteriol. 1955 Sep; 70(3): 297-304.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=357685
TULAREMIA.
Levin W.
Bull Med Libr Assoc. 1940 Oct; 29(1): 17-22.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=233540
Francisella tularensis Bacteremia.
Haristoy X, Lozniewski A, Tram C, Simeon D, Bevanger L, Lion C.
J Clin Microbiol. 2003 Jun; 41(6): 2774-2776.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=156490
Antibiotic prophylaxis and therapy of airborne tularemia.
Sawyer WD, Dangerfield HG, Hogge AL, Crozier D.
Bacteriol Rev. 1966 Sep; 30(3): 542-550.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=378237
Bactericidal Activities of Antibiotics against Intracellular Francisella tularensis.
Maurin M, Mersali NF, Raoult D.
Antimicrob Agents Chemother. 2000 Dec; 44(12): 3428-3431.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=90216
Tularemia.
Ellis J, Oyston PC, Green M, Titball RW.
Clin Microbiol Rev. 2002 Oct; 15(4): 631-646.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=126859
STUDIES ON TULAREMIA: III. The Variation of Pasteurella tularensis Grown in the Presence of Normal and Immune Serum from Various Hosts.
Moody MD.
J Bacteriol. 1955 Sep; 70(3): 314-319.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype;=pdf&artid;=357687
Back to Top
H1N1 (Swine) Flu/Tamiflu/Pandemic Flu
H1N1 (Swine) Flu
Cases of Swine Influenza in Humans: A Review of the Literature
Kendall P. Myers, Christopher W. Olsen, and Gregory C. Gray
Clin Infect Dis. Author manuscript; available in PMC 2007 September 7.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1973337&blobtype=pdf
The Failure of the 1976 Swine Influenza Immunization Program
Sharon L. Begley
Yale J Biol Med. 1977 Nov–Dec; 50(6): 645–656.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2595572&blobtype=pdf
Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin
Alexandra P. Newman, Erik Reisdorf, Jeanne Beinemann, Timothy M. Uyeki, Amanda Balish, Bo Shu, Stephen Lindstrom, Jenna Achenbach, Catherine Smith, and Jeffrey P. Davis
Emerg Infect Dis. 2008 September; 14(9): 1470–1472. doi: 10.3201/eid1409.080305.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2603093&blobtype=pdf
An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza.
D E Wentworth, B L Thompson, X Xu, H L Regnery, A J Cooley, M W McGregor, N J Cox, and V S Hinshaw
J Virol. 1994 April; 68(4): 2051–2058.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=236678&blobtype=pdf
Tamiflu
Experts question wisdom of stockpiling oseltamivir
Andrew Cole
BMJ. 2005 November 5; 331(7524): 1041.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1283174&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1283174&tool=pmcentrez#supplementary-material-sec
Health and Drug Alerts: Oseltamivir (Tamiflu) unsafe in infants under 1 year old
Eric Wooltorton
CMAJ. 2004 February 3; 170(3): 336.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=331382&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=331382&tool=pmcentrez#supplementary-material-sec
Meeting Report: Risk Assessment of Tamiflu Use Under Pandemic Conditions
Andrew C. Singer, Bruce M. Howard, Andrew C. Johnson, Chris J. Knowles, Simon Jackman, Cesare Accinelli, Anna Barra Caracciolo, Ian Bernard, Stephen Bird, Tatiana Boucard, Alistair Boxall, Jayne V. Brian, Elise Cartmell, Chris Chubb, John Churchley, Sandra Costigan, Mark Crane, Michael J. Dempsey, Bob Dorrington, Brian Ellor, Jerker Fick, John Holmes, Tom Hutchinson, Franz Karcher, Samuel L. Kelleher, Peter Marsden, Gerald Noone, Miles A. Nunn, John Oxford, Tony Rachwal, Noel Roberts, Mike Roberts, Maria Ludovica Saccà, Matthew Sanders, Jürg Oliver Straub, Adrian Terry, Dean Thomas, Stephen Toovey, Rodney Townsend, Nikolaos Voulvoulis, and Chris Watts
Environ Health Perspect. 2008 November; 116(11): 1563–1567.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2592279&blobtype=pdf
Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza
Walter R. J. Taylor, Bui Nghia Thinh, Giang Thuc Anh, Peter Horby, Heiman Wertheim, Niklas Lindegardh, Menno D. de Jong, Kasia Stepniewska, Tran Thuy Hanh, Nguyen Duc Hien, Ngo Minh Bien, Ngo Quy Chau, Annette Fox, Nghiem My Ngoc, Martin Crusat, Jeremy J. Farrar, Nicholas J. White, Nguyen Hong Ha, Trinh Thi Lien, Nguyen Vu Trung, Nicholas Day, and Nguyen Gia Binh
PLoS ONE. 2008; 3(10): e3410.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2565445&blobtype=pdf
Oseltamivir Prescribing in Pharmacy-Benefits Database, United States, 2004–2005
Justin R. Ortiz, Laurie Kamimoto, Ronald E. Aubert, Jianying Yao, David K. Shay, Joseph S. Bresee, and Robert S. Epstein
Emerg Infect Dis. 2008 August; 14(8): 1280–1283.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2600408&blobtype=pdf
Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid
Mark Holodniy, Scott R. Penzak, Timothy M. Straight, Richard T. Davey, Kelvin K. Lee, Matthew Bidwell Goetz, Dennis W. Raisch, Francesca Cunningham, Emil T. Lin, Noemi Olivo, and Lawrence R. Deyton
Antimicrob Agents Chemother. 2008 September; 52(9): 3013–3021.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2533494&blobtype=pdf
Potential Risks Associated with the Proposed Widespread Use of Tamiflu
Andrew C. Singer, Miles A. Nunn, Ernest A. Gould, and Andrew C. Johnson
Environ Health Perspect. 2007 January; 115(1): 102–106.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1797841&blobtype=pdf
A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination
Dennis Morrison, Sandip Roy, Craig Rayner, Ahmed Amer, Dan Howard, James R. Smith, and Thomas G. Evans
PLoS ONE. 2007; 2(12): e1305. Published online 2007 December 12.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2110886&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2110886&tool=pmcentrez#supplementary-material-sec
Reassessing the Risks of Tamiflu Use during a Pandemic to the Lower Colorado River
Andrew C. Singer, Andrew C. Johnson, Paul D. Anderson, and Shane A. Snyder
Environ Health Perspect. 2008 July; 116(7): A285–A286.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2453174&blobtype=pdf
Review says oseltamivir and zanamivir should be kept for epidemics of flu
Susan Mayor
BMJ. 2006 January 28; 332(7535): 196.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1352045&blobtype=pdf
Stockpiling oseltamivir: What is the number needed to treat with oseltamivir to prevent one flu death?
A Rouse
BMJ. 2005 November 19; 331(7526): 1203.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1285142&blobtype=pdf
Tamiflu Swan Song?: Building Resistance to Top Avian Flu Drug
Cynthia Washam
Environ Health Perspect. 2007 January; 115(1): A42.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1797873&blobtype=pdf
Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
Terry G. Besselaar, Dhamari Naidoo, Amelia Buys, Vicky Gregory, Jo McAnerney, Jack M. Manamela, Lucille Blumberg, and Barry D. Schoub
Emerg Infect Dis. 2008 November; 14(11): 1809–1810. doi: 10.3201/eid1411.080958.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2630761&blobtype=pdf
Pandemic Flu
Antiviral Resistance and the Control of Pandemic Influenza
Marc Lipsitch, Ted Cohen, Megan Murray, and Bruce R Levin
PLoS Med. 2007 January; 4(1): e15.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1779817&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1779817&tool=pmcentrez#supplementary-material-sec
Being prepared: Preparations for a pandemic of influenza.
Owens SR.
EMBO Rep. 2001 Dec 15; 2(12): 1061-1063.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1084177
BREAKING THE CODE: Predicting Where Disease Will Strike.
Lougheed T.
Environ Health Perspect. 2005 Sep; 113(9): A610-A613.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1332002
Confined Animal Feeding Operations as Amplifiers of Influenza
ROBERTO A. SAENZ, HERBERT W. HETHCOTE, and GREGORY C. GRAY
Vector Borne Zoonotic Dis. Author manuscript; available in PMC 2007 October 26.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2042988&blobtype=pdf
Current and future antiviral therapy of severe seasonal and avian influenza
John Beigel and Mike Bray
Antiviral Res. Author manuscript; available in PMC 2009 April 1.
PMCID: PMC2346583
Published in final edited form as: Antiviral Res. 2008 April; 78(1): 91–102. Published online 2008 February 4. doi: 10.1016/j.antiviral.2008.01.003.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2346583&blobtype=pdf
Delaying the International Spread of Pandemic Influenza.
Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ.
PLoS Med. 2006 Jun; 3(6): e212. published online before print May 2, 2006
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1450020
Supplemental Data
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1450020#supplementary-material-sec
Economical laboratory support system for influenza virus surveillance.
Reichelderfer PS, Kappus KD, Kendal AP.
J Clin Microbiol. 1987 May; 25(5): 947-948.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=266129
Evaluation of the Directigen FluA+B Test for Rapid Diagnosis of Influenza Virus Type A and B Infections.
Chan KH, Maldeis N, Pope W, Yup A, Ozinskas A, Gill J, Seto WH, Shortridge KF, Peiris JS.
J Clin Microbiol. 2002 May; 40(5): 1675-1680.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=130655
The evolutionary emergence of pandemic influenza
Troy Day, Jean-Baptiste André, and Andrew Park
Proc Biol Sci. 2006 December 7; 273(1604): 2945–2953.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1639509&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1639509&tool=pmcentrez#supplementary-material-sec
Factors that make an infectious disease outbreak controllable.
Fraser C, Riley S, Anderson RM, Ferguson NM.
Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16): 6146-6151. published online before print April 7, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=395937
Influenza: Emergence and Control
Aleksandr S. Lipatov, Elena A. Govorkova, Richard J. Webby, Hiroichi Ozaki, Malik Peiris, Yi Guan, Leo Poon, and Robert G. Webster
J Virol. 2004 September; 78(17): 8951–8959.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=506949&blobtype=pdf
Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study
Ivar S Kristiansen, Peder A Halvorsen, and Dorte Gyrd-Hansen
BMC Public Health. 2007; 7: 48
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1852795&blobtype=pdf
Influenza pandemic and professional duty: family or patients first? A survey of hospital employees
Boris P Ehrenstein, Frank Hanses, and Bernd Salzberger
BMC Public Health. 2006; 6: 311.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1764890&blobtype=pdf
Influenza Seasonality: Underlying Causes and Modeling Theories
Eric Lofgren, N. H. Fefferman, Y. N. Naumov, J. Gorski, and E. N. Naumova
J Virol. 2007 June; 81(11): 5429–5436.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1900246&blobtype=pdf
Modeling the effects of drug resistant influenza virus in a pandemic
Stefan O Brockmann, Markus Schwehm, Hans-Peter Duerr, Mark Witschi, Daniel Koch, Beatriz Vidondo, and Martin Eichner
Virol J. 2008; 5: 133. Published online 2008 October 30. doi: 10.1186/1743-422X-5-133.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2590604&blobtype=pdf
Supplementary material: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2590604&tool=pmcentrez#supplementary-material-sec
Monitoring the Impact of Influenza by Age: Emergency Department Fever and Respiratory Complaint Surveillance in New York City
Donald R Olson, Richard T Heffernan, Marc Paladini, Kevin Konty, Don Weiss, and Farzad Mostashari
PLoS Med. 2007 August; 4(8): e247.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1939858&blobtype=pdf
Supplementary material: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1939858&tool=pmcentrez#supplementary-material-sec
Pandemic Influenza: The Inside Story.
Nicholls H.
PLoS Biol. 2006 Feb; 4(2): e50. published online before print February 14, 2006
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1363710
Pandemic Influenza and Pregnant Women
Sonja A. Rasmussen, Denise J. Jamieson, and Joseph S. Bresee
Emerg Infect Dis. 2008 January; 14(1): 95–100.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2600164&blobtype=pdf
Pandemic Influenza: Risk of Multiple Introductions and the Need to Prepare for Them.
Mills CE, Robins JM, Bergstrom CT, Lipsitch M, , , ,.
PLoS Med. 2006 Jun; 3(6): e135. published online before print February 21, 2006
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1370924
Supplemental Data
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1370924#supplementary-material-sec
The Pathology of Influenza Virus Infections
Jeffery K. Taubenberger and David M. Morens
Annu Rev Pathol. Author manuscript; available in PMC 2008 August 11.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2504709&blobtype=pdf
Personal Protective Equipment and Risk for Avian Influenza (H7N3)
Oliver Morgan, Mirjam Kuhne, Pat Nair, Neville Q. Verlander, Richard Preece, Marianne McDougal, Maria Zambon, and Mark Reacher
Emerg Infect Dis. 2009 January; 15(1): 59–62.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2662632&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2662632&tool=pmcentrez#supplementary-material-sec
The potential impact of the next influenza pandemic on a national primary care medical workforce.
Wilson N, Baker M, Crampton P, Mansoor O.
Hum Resour Health. 2005; 3: 7. published online before print August 11, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1215505
Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households
Benjamin J. Cowling, Rita O. P. Fung, Calvin K. Y. Cheng, Vicky J. Fang, Kwok Hung Chan, Wing Hong Seto, Raymond Yung, Billy Chiu, Paco Lee, Timothy M. Uyeki, Peter M. Houck, J. S. Malik Peiris, and Gabriel M. Leung
PLoS ONE. 2008; 3(5): e2101.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2364646&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2364646&tool=pmcentrez#supplementary-material-sec
Protecting residential care facilities from pandemic influenza
M. Nuño, T. A. Reichert, G. Chowell, and A. B. Gumel
Proc Natl Acad Sci U S A. 2008 July 29; 105(30): 10625–10630
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2492509&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2492509&tool=pmcentrez#supplementary-material-sec
Reducing the Impact of the Next Influenza Pandemic Using Household-Based Public Health Interventions
Joseph T Wu, Steven Riley, Christophe Fraser, and Gabriel M Leung
PLoS Med. 2006 September; 3(9): e361.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1526768&blobtype=pdf
Supplementary materials: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1526768&tool=pmcentrez#supplementary-material-sec
School Closure to Reduce Influenza Transmission
Lisa M. Koonin and Martin S. Cetron
Emerg Infect Dis. 2009 January; 15(1): 137–138.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2660715&blobtype=pdf
Toward a broadly protective influenza vaccine
Peter C. Doherty and Anne Kelso
J Clin Invest. 2008 October 1; 118(10): 3273–3275. Published online 2008 September 18.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2542858&blobtype=pdf
Zanamivir, influenza, and meningococcal disease : Zanamivir may help to fight potential flu epidemic.
Green ST.
BMJ. 2000 Feb 5; 320(7231): 378.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1127153
Back to Top